Over the last decades, more attention had been paid to find ways to stimulate the regeneration of the infarcted heart. However, some obstacles should be overcome before it can be applied to patients on a large scale.
The bromodomain and extra-terminal (BET) family proteins modulate chromatin structure and influence gene transcription. 5 Previous studies have indicated a central role of BET proteins in regulating gene expression during heart failure pathogenesis. 6 JQ1 is a potent BET family proteins inhibitor and is widely used in laboratory research to probe BET function in various diseases. 7 BET inhibition suppresses cardiomyocyte hypertrophy in vitro and pathological cardiac remodeling in vivo, 8 furthermore, the inhibition of BET family proteins using JQ1 could suppress acute myocardial infarction (AMI) via TLR4/ TRAF6/NF-κB signaling pathway. 5 BRD4 belongs to the BET proteins, which act as "readers" of acetylated lysines on chromatin to regulate gene transcription. Inhibition of this protein is currently being explored for the treatment of several types of cancer. 9 The biological function of BRD4 in heart is still not clear. NPPA and NPPB are functional genes of the myocardium, which could be upregulated in the process of cardiomyocyte differentiation. 10 Spiltoir et al showed that BRD4 protein expression was increased during cardiac hypertrophy, and hypertrophic stimuli promoted recruitment of BRD4 to the transcriptional start site of the NPPA gene, a classical bio-marker in HF, which suggested that BRD4 play important roles in cardiac reprograming during HF.
However, the role of BRD4 protein and the underlying mechanism remain unclear in other heart disease, such as MI.
Cardiomyocyte apoptosis leads to activation of the complement system and toll-like receptors (TLRs), as well as the generation of free radicals that stimulate nuclear factor kappa B (NF-κB) in cardiomyocytes, 11 thereby inducing expression of cytokines, chemokines, and adhesion molecules. 12 NF-κB p50/p65 heterodimer is a key mediator of inflammation. It is one of the most avidly forming dimmers and is the major complex in most cells, is commonly referred specifically and hereinafter as NF-κB. 13 Based on previous observation of Zou et al, which identified a novel function of Brd4 in maintaining the persistently active form of NF-κB found in tumors, and interference with the interaction between acetylated RelA and Brd4 could be a potential therapeutic approach for the treatment of NF-κB-driven cancer, 14 we speculate that BRD4 might cooperate with acetylated RelA during MI.
| MATERIALS AND METHODS

| Ethics statement
All animals used in this study received humane care in compliance with the guide for the care and use of laboratory animals, NIH Publication, 1996 edition, and all the protocols were approved by the Animal Subjects Committee of Tianjin Medical University.
| AMI rat model
A total of 30 female adult Sprague-Dawley rats (age, 8-10 weeks;
weight, 250-300 g) were provided by the Beijing Huafukang Biotechnology (Beijing, China) and divided into the sham group (n = 15) and the AMI group (n = 15). The experimental AMI model was induced by the ligation of left coronary artery in adult Sprague-Dawley rats, as previously described. 15 Briefly, the rats were anesthetized intraperitoneally with 80 mg/kg ketamine and 5 mg/kg xylazine, and the left anterior descending coronary artery was ligated by a silk suture. A successful intervention was demonstrated by elevated ST segments on an electrocardiogram (MAC 1600; GE Healthcare, Pittsburgh, PA, USA), and the average infarct size of our MI model is ~40%. In the sham group, rats were exposed to all surgical procedures except the occlusion of the anterior descending coronary artery. Rats in each group were divided into 3 subgroups for RNA isolation (n = 5), protein preparation (n = 5), and histological staining (n = 5), respectively. At the indicated time following the surgical intervention, the rats were sacrificed by intraperitoneal injection of 200 mg/kg pentobarbital (Sigma-Aldrich, St. Louis, MO, USA), and the rat hearts were excised for 4% paraformaldehyde fixation or stored at −80°C.
| Pressure-volume conductance catheter technique
The left ventricular ejection fraction (LVEF) and fraction shortening (LVFS) indices of cardiac function were also measured using the pressure-volume conductance catheter technique as previous references reported. 16 Briefly, rats were anesthetized and placed on the controlled heating pads, the intubation was inserted into the trachea through the mouth, and the core body temperature was measured 
| Lentivirus packaging
The group of 30 SD rats was subdivided into two groups of fifteen receiving either rat-Brd4-shRNA (shBRD4) or nontarget control (Ctrl) lentivirus particles, respectively (Origene, Rockville, MD, USA). Two animals in the shBRD4 group and one animal in the Ctrl group died during the gene transfer surgery. The group of 24 sham-operated rats was subdivided into 2 groups of 12, with each group receiving either shBRD4 or Ctrl. One rat in the shBRD4 group and one rat in the Ctrl group died during the gene transfer surgery.
| Cardiomyocyte culture
Primary culture of neonatal cardiomyocytes was prepared as described. 17 Briefly, hearts from 1-to 3-day-old Sprague-Dawley rats were dissected and the ventricles were minced into small pieces.
The tissues were transferred to digestion solution containing 0.1% collagenase type IV, 0.1% trypsin, 15 μg/mL DNase I and 1% fetal bovine serum in HEPES-buffered saline, then incubated at 37°C for 
| Ultrasonic cardiogram
Transthoracic echocardiography was assessed before MI and 4 weeks after MI. After general anesthesia, all the measurements were performed under repeated, short end-expiratory breath holds.
Transthoracic 2D echocardiography was performed with a dynamic 
| RNA isolation and real-time quantitative PCR
Total RNA was isolated using TRizol Reagent (Invitrogen, Life 
| Western blot
Whole cell lysates were prepared in RIPA buffer containing protease inhibitors and western blotting was performed as described previously. 18 Protein concentrations were measured using a protein assay kit (Pierce, Thermal Fisher, Rockford, IL, USA). Samples with equal amounts of protein were loaded onto 10% polyacryla- Tris, 500 mmol/L sodium chloride, pH 7.5) containing 5% dry milk. 
| Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay
To measure the apoptotic activity of cardiomyocytes indicated by 
| Co-immunoprecipitation (Co-IP)
Cells were lysed in cell lysis buffer (20 mM HEPES-KOH pH 7.5, 150 mmol/L NaCl, 2 mmol/L EDTA, 1% Triton X-100) containing Halt protease inhibitor cocktail (Thermo Fisher Scientific, Cat#: 78430).
Lysates were incubated with 1 μg of antibody or control rabbit or mouse IgG (Cell Signaling Technology, Cat#: 2729S and 5415S) at 4°C
overnight followed by incubation with 50 μL of Dynabeads Protein G (Thermo Fisher Scientific, Cat# 10004D) for 3 hours. After washing 3 times with cell lysis buffer containing 0.05% NP-40, immunoprecipitates were resuspended in 1 × SDS-PAGE sample buffer and resolved by SDS-PAGE followed by western blot analysis.
| Chromatin immunoprecipitation (ChIP)
Briefly, hearts were exposed to 1% formaldehyde for 10 minutes to crosslink and maintain DNA/protein interactions. After the reactions were stopped with glycine, hearts were washed, chromatin isolated, and the DNA sheared into fragments (100-500 base pairs) using a sonicator. ChIP reactions were performed using GR antibody to precipitate the transcription factor/DNA complex. Cross-linking was then reversed using a salt solution and proteins digested with proteinase K. To quantify PCR amplification, real-time PCR was carried out with 5 minutes initial denaturation followed by 45 cycles of 95°C for 10 seconds, 56°C for 30 seconds, and 72°C for 10 seconds, using the CFX96 real-time PCR thermal cycler (Bio-Rad).
| Histological staining
Heart tissue samples were fixed in 4% neutral-buffered formalin. After 
| Statistical analysis
All data represent the mean ± SD of 3 independent experiments.
Statistical analyses were performed using the SPSS version 13.0 program (SPSS Inc., Chicago, IL, USA). Differences between groups were analyzed using Student's t test and P < .05 was considered to indicate statistical significance.
| RESULTS
| BRD4 expression is upregulated in the ischemic myocardium
To determine the biological function of BET proteins in ischemic myocardium, the AMI rat model was constructed., Myocardial infarcts post AMI were measured by HE staining, the MI group exhibited more damaged cells relative to the sham group ( Figure 1A) , and we also confirmed that significant apoptosis was induced in the MI myocardiocytes, because the cleavage of PARP and caspase-3 proteins were obviously activated as the western blotting results showing ( Figure 1B) . Furthermore, 2 weeks after the AMI, the scores of LVEF and LVFS in the MI group decreased significantly ( Figure 1C ).
BET family protein expression levels were analyzed by RT-PCR, we found that the mRNA level of BRD2 and BRD3 showed little change, however, the expression of BRD4 was greatly increased ( Figure 1D ), in addition, the western blot assay showed that BRD4, as well as protein coded by the AMI related genes NPPA and NPPB, were remarkable upregulated, which was consistent with the mRNA level change Figure 1E ). Through the bioinformatics analysis, we found that BRD2, BRD3, and BRD4 maintained lower expression levels in adult heart than in the fetal heart, which suggested that BET proteins played important roles in heart development and heart disease ( Figure S1 ).
| BRD4 expression is upregulated in cardiomyocytes exposed to hypoxia
To further examine the biological function of BRD4, the cardiomyocytes were cultured in vitro and exposed to hypoxia to imitate the hypoxia-ischemia situation. The real-time quantitative PCR assay indicated that BRD4 was significantly upregulated 6 hours ( Figure 2A) and 24 hours ( Figure 2B ) after MI. However, the protein level of BRD2
and BRD3 was more insensitive in response to hypoxia-ischemia treatment ( Figure 2C ).
| Silencing BRD4 inhibits the apoptosis occurrence in cardiomyocytes exposed to hypoxia
The shRNA targeting BRD4 was successfully constructed and transferred to the cardiomyocytes, the western blot assay suggested that the BRD4 protein could be significantly knocked down, which was similar to blocking BRD4 using its inhibitor JQ-1 ( Figure 3A) . Then, the apoptosis occurrence was detected via TUNEL assay. We found that silencing BRD4 could reduce the apoptosis rate in both shBRD4 group and JQ-1 group compared with scramble group (Figure 3B,C) .
Taken together, these results implicated that elevated expression of BRD4 was supposed to play pro-apoptosis function in MI progression.
| Silencing BRD4 alleviates the MI-induced injury in vivo
From the base data, we hypothesis that knockdown of BRD4 in vivo might alleviate the MI-induced injury, so the lentivirus carrying the shRNA targeting BRD4 was administered into the tail vein at 8 days before MI surgery The protein level of heart BRD4 was effectively downregulated in vivo when checked using the western blotting for the myocardiocytes ( Figure 4A ). In addition, histological staining
showed that the MI-induced cellular damage could be improved via BRD4 knockdown ( Figure 4B ). The expression of AMI related genes, such as NPPA and NPPB, were significantly downregulated via inhibiting the BRD4 expression ( Figure 4C ). Furthermore, the LVEF and the LVFS scores were also improved when BRD4 was knocked down ( Figure 4D ). These results clearly indicate that silencing BRD4 could improve the MI-induced injury in vivo.
| BRD4 binds with acetylated RelA to influence NF-κB pathway in MI
As indicated, the nuclear functions of NF-κB p50/RelA heterodimers are regulated in part by acetylation of its RelA subunit, which plays important roles in MI. 19 In this study, we investigated whether BRD4 plays any role in the NF-κB signaling governed regulation. The Co-IP assay indicated that acetylation RelA could bind with BRD4 in cardiomyocytes exposed to hypoxia, however, acetylation RelA binds with nearly no BRD4 in normal condition ( Figure 5A ). In addition, the ChIP assay was used to detect the recruitment amount of BRD4 in NPPA and NPPB gene promoters, in which we found that under hypoxia stimulation, the BRD4 recruitment amount was significantly upregulated compared with normal condition both on the NPPA or NPPB promoter ( Figure 5B ). large MI, the infarcted heart progressively dilates and accelerates the deterioration of ventricular dysfunction that eventually results in heart failure. 20 In the current study, we found different expression level of BET family proteins between adult and fetal hearts through bioinformatics analysis in GeneCards (http://www.genecards.org/), and we investigated whether they play important roles in the cardiac remodeling.
| DISCUSSION
Several BET bromodomain inhibitor drugs are currently being developed in early-phase human cancer trials. 21 In the field of heart study, Duan et al provide impetus for next-phase testing of this class of therapeutics in large animal models of HF, including porcine/ovine MI models, and they focused on the ability of JQ-1 to ameliorate severe HF that occurs after a complete and dense anterior wall MI. Their findings, which highlight the beneficial effects of JQ-1 on the remote/ non-infarcted myocardium, are relevant for the treatment of ischemic cardiomyopathy in humans. 22 In the progress of MI and HF, the BET family expression and the biological function needs to be clarified. In a previous study, specific shRNA-mediated silencing of BRD4 in cultured cardiomyocytes was shown to mimic the antihypertrophic effect of JQ-
1.
23 BRD4 is also the BET family member that allosterically activates the P-TEFb complex via a C-terminal CDK9-interacting domain, that is, not present in BRD2 or BRD3, 24 which is consistent with our observation that JQ1 suppresses Pol II pause release in the stressed heart.
23
Together, these findings strongly implicate cardiac BRD4 as a major target of JQ-1 in this context, but the mechanism by which small-molecule BET bromodomain inhibitor mediate the therapeutic effects, especially the target protein and cell types, should be further investigated.
Studies have shown that, in myocardial insults, proinflammatory cytokines are found elevated and are greatly dependent upon the activation of NF-κB. 25 Functionally, NF-κB exists as a dimer of proteins from the NF-κB family of genes: nfkb1, nfkb2, rel, rela, and relb. The most studied of these genes is rela, which encodes a 60 kDa protein, RelA/p65, referred to as p65 from here on. 26 As indicated, the nuclear functions of NF-κB p50/RelA heterodimers are regulated in part by posttranslational modifications of its RelA subunit, including phosphorylation and acetylation. 19 Acetylation of the RelA subunit of NF-κB regulates the transcriptional activation of NF-κB target genes and contributes to maintaining constitutively active NF-κB in tumors.
In addition, NF-κB signaling pathway plays important roles in the MI process, in which RelA was also acetylated. In the current study, we found that knocking down BRD4 could inhibit apoptosis in vitro and alleviate MI in vivo. Furthermore, we demonstrated that BRD4 could coactivate NF-κb pathway via specific binding to acetylated RelA.
Taken together, our study highlights the role of BRD4 in attenuating 
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